Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Dec 21;3(12):e0002256. doi: 10.1371/journal.pgph.0002256

Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: A mixed methods study

Tinotenda Taruvinga 1,2,3,*, Rudo S Chingono 1, Edson Marambire 1,4, Leyla Larsson 1,4, Ioana D Olaru 1,5, Sibusisiwe Sibanda 1, Farirai Nzvere 1, Nicole Redzo 1, Chiratidzo E Ndhlovu 6, Simbarashe Rusakaniko 7, Hilda Mujuru 8, Edwin Sibanda 9, Prosper Chonzi 10, Maphios Siamuchembu 11, Rudo Chikodzore 12, Agnes Mahomva 13, Rashida A Ferrand 1,5, Justin Dixon 1,2,#, Katharina Kranzer 1,4,5,#
Editor: Oghenebrume Wariri14
PMCID: PMC10734954  PMID: 38127934

Abstract

With COVID-19 no longer categorized as a public health emergency of international concern, vaccination strategies and priority groups for vaccination have evolved. Africa Centres for Diseases Prevention and Control proposed the ‘100-100-70%’ strategy which aims to vaccinate all healthcare workers, all vulnerable groups, and 70% of the general population. Understanding whether healthcare workers were reached during previous vaccination campaigns and what can be done to address concerns, anxieties, and other influences on vaccine uptake, will be important to optimally plan how to achieve these ambitious targets. In this mixed-methods study, between June 2021 and July 2022 a quantitative survey was conducted with healthcare workers accessing a comprehensive health check in Zimbabwe to determine whether and, if so, when they had received a COVID-19 vaccine. Healthcare workers were categorized as those who had received the vaccine ‘early’ (before 30.06.2021) and those who had received it ‘late’ (after 30.06.2021). In addition, 17 in-depth interviews were conducted to understand perceptions and beliefs about COVID-19 vaccines. Of the 3,086 healthcare workers employed at 43 facilities who participated in the study, 2,986 (97%, 95% CI [92%-100%]) reported that they had received at least one vaccine dose. Geographical location, older age, higher educational attainment and having a chronic condition was associated with receiving the vaccine early. Qualitatively, (mis)information, infection risk perception, quasi-mandatory vaccination requirements, and legitimate concerns such as safety and efficacy influenced vaccine uptake. Meeting the proposed 100-100-70 target entails continued emphasis on strong communication while engaging meaningfully with healthcare workers’ concerns. Mandatory vaccination may undermine trust and should not be a substitute for sustained engagement.

Introduction

Coronavirus disease 2019 (COVID-19) vaccines have been a key pillar of the pandemic response at global, national, and local levels. Their roll-out has reduced morbidity, severity and deaths as reported in many vaccine effectiveness studies [13]. However, the hoarding of vaccines by wealthier countries (i.e. ‘vaccine nationalism’) and global unequal vaccine distribution limited the availability of COVID-19 vaccines, especially in low- and middle-income countries (LMICs) [4, 5], resulting in slow and often erratic roll out [5]. In response to vaccine nationalism and accessibility challenges, various international platforms were created to increase vaccine availability in LMICs, including the COVID-19 vaccine delivery partnership (CoVDP) (which is an alliance of the WHO, UNICEF and GAVI) and the COVID-19 vaccines global access (COVAX) platform [4, 6]. While many LMICs signed up to the COVAX initiative, others opted for bilateral arrangements [7]. For instance, Zimbabwe the focus of our research, did not initially sign up to the COVAX initiative and instead obtained vaccines through bilateral arrangements with China, Russia and India [4, 7].

To optimize the use of limited and often unpredictable supply of vaccines, Zimbabwe like many LMICs used a phased approach that prioritized at-risk groups for vaccination, including healthcare workers [8, 9]. Prioritizing and ensuring high vaccine uptake among healthcare workers was important for several reasons. First, healthcare workers were widely recognized as being at heightened risk of COVID-19, as reflected in the high mortality rate during the pandemic [10, 11]. Second, vaccination among healthcare workers has further ramifications in terms of preventing nosocomial transmission and more broadly for ensuring the human resourcing of health systems [12, 13]. Third, vaccine uptake among healthcare workers has a considerable influence on uptake among the general population [9, 13]. Studies from both high-income countries and LMICs suggest a considerable proportion of the general population would consider healthcare workers’ advice before vaccination [1416].

Vaccine strategies have evolved over the last two years and new recommendations on who should be prioritized for COVID-19 vaccination have been released. On the 5th of May 2023, the WHO has de-escalated the COVID-19 pandemic as a public health emergency of international concern [17]. Related to the new recommendations, Africa CDC in their new strategy have maintained healthcare workers as a priority group with a target set to reach 100% (timeline for target unspecified) COVID-19 vaccine coverage among this group [18]. In view of this ambitious target of vaccinating all healthcare workers, it is crucial to understand whether past COVID-19 vaccination strategies were successful and what could be done to address healthcare workers’ perceptions, anxieties, and concerns to reach the ambitious 100% target. Strategies to achieve universal vaccine coverage will likely need to be context-sensitive and informed by actual uptake data during the pandemic. In this mixed-methods study, we sought to understand vaccine uptake by describing the ‘early’ and ‘late’ uptake, including qualitatively exploring the perceptions, and attitudes among healthcare workers in Zimbabwe.

Methods

Study design

Data was collected as part of a broader study providing a comprehensive health check to healthcare workers in Zimbabwe which has been described in detail elsewhere [19]. A quantitative survey and in-depth interviews were conducted with selected healthcare workers accessing the comprehensive health check service between June 2021 and July 2022.

Study setting and population

Zimbabwe is a low-income country with a long history of severe economic decline affecting healthcare services, public health programmes, and epidemic management capacity [20, 21]. During the study period, healthcare workers had taken up industrial action over low wages and unavailability of adequate personal protective and medical equipment [20, 22]. The study was conducted in public hospitals across all ten provinces in Zimbabwe and primary care clinics in Harare, Matabeleland North, and Mashonaland East. The study participants were clinical and non-clinical healthcare workers who accessed the comprehensive health check service.

Zimbabwe’s COVID-19 vaccination campaign

Zimbabwe launched its COVID-19 vaccination campaign on 22 February 2021 and started distributing booster doses in December 2021 [23, 24]. The country approved the use of Sinopharm and Sinovac vaccines before they had received Emergency Authorization Use (EAU) by the WHO [25], followed by Covax, Sputnik V and Johnson and Johnson [26]. However, only Sinopharm and Sinovac were readily available in the public sector [27].

Vaccines were supplied in batches and were initially distributed primarily in Harare and Bulawayo (the two largest cities in Zimbabwe) which had reported the highest number of SARS-CoV-2 infections. Other provinces received vaccines as the supply chain improved. By 31 July 2022, an estimated 11,8 million doses had been administered, resulting in a target population coverage of 53.2% for the first dose, 41.3% for the second dose, and 7.4% for the third dose [28]. Fig 1 shows administered vaccine doses and SARS-CoV-2 infections over time. The highest number of vaccine doses were administered during the COVID-19 pandemic third wave, which was primarily driven by the more contagious SARS-CoV-2 delta variant and resulted in the highest number of deaths.

Fig 1. Routine data on vaccine doses administered and notified SARS-CoV-2 infections obtained from the daily published Ministry of Health and Child Care situational reports.

Fig 1

Procedures

Prior to accessing the health check services, verbal informed consent was obtained. Data on age, sex, professional role, education, clinical history, past SARS-CoV-2 infection and COVID-19 vaccination history, and perceived vaccine safety were obtained from all the healthcare workers accessing the service. The quantitative component involved a questionnaire based on a WHO survey tool [18] which asked about COVID-19 vaccinations history and perceived vaccine safety in addition to the already provided socio demographics and clinical history data. Subsequent to the questionnaire and health check, written informed consent was obtained from a sub-set of healthcare workers purposively (i.e. identifying participants sharing particular characteristics not seeking a representative sample but rather a non-probability sample focused on identifying participants fitting the objectives of the study, [29]) selected for in-depth interviews [30] based on the vaccination status, the time of their first vaccination dose and the place they worked. The in-depth interviews were administered using a topic guide. This was to better understand healthcare workers reasons for taking or not taking up the COVID-19 vaccine and the challenges they may have faced in the process.

A total of 17 in-depth interviews were conducted, after reaching a data saturation point (i.e. when we were no longer generating new information to existing categories) [30]. A topic guide was developed prior to the interview and included questions about participants’ vaccination status, challenges of accessing vaccines, concerns about vaccine safety, reasons for being vaccinated or not, and sources of information to guide decision-making. During interviews, participants were given a broader remit to discuss more general concerns and anxieties, as well as why there were these concerns in context, including what specifically concerned them as healthcare workers. While the questions asked as part of the quantitative questionnaire specifically asked about personal reasons for not getting vaccinated (if they had not been vaccinated), the in-depth interview guide gave healthcare workers room to express both positive and negative anxieties they had and those their patients, families and communities may have voiced. Both the questionnaire and interviews were conducted in English, Ndebele, or Shona according to the participant’s choice. Interviews lasted between 30 to 75 minutes while interviewing stopped after exhausting all possible probing questions (i.e., questions that enable you to follow up on areas of interest related to an overarching theme, some of which might not be predictable in advance [30]). This was done to explore, in greater detail respondents’ perceptions and feelings about taking up or not taking up the COVID-19 vaccines.

Data management and analysis

Quantitative data were collected using electronic real time data entry (SurveyCTO). Electronic questionnaires were uploaded daily and saved to a Microsoft SQL server. Participants were identified by a unique identification number. The data was analysed in R version 4.1.2. Means with associated standard deviations (SD) were computed for normally distributed continuous variables; medians and interquartile ranges (IQR) were analysed for non-normality distributed continuous variables. Absolute counts and proportions for categorical variables were calculated. The main outcome variable was receiving the vaccine ‘early’ or ‘late’. Healthcare workers categorised as receiving the vaccine “early” were defined as having received the first vaccine dose between 22nd of February and 30th of June 2021, while those receiving the first vaccine dose after June 2021 were categorised as “late”. Those who did not have a response to the vaccination variable were excluded from analysis.

A multivariable logistic regression was conducted to investigate associations between client characteristics (sex, age, occupation, comorbidities, province of origin, administrative authority, and prior history of SARS-CoV-2 infection) and receiving the vaccine “late”. Variables included in the final model were purposefully selected and analysis was conducted on a complete observation set. P-values were derived using a likelihood ratio test. Results are reported as adjusted odds ratios (aOR) along with their corresponding 95% confidence intervals (95% CI). Those who did not take the vaccine were excluded from the main regression analysis but were however included in the “late” vaccination group in a sensitivity analysis (whose results we have shown in S1 Table).

Staff roles were categorised into clinical and non-clinical, where clinical staff included, nurses, doctors, laboratory technicians, nurse aides, radiographers, rehabilitation technicians, and pharmacists. Non-clinical staff included administrators, environmental health practitioners, security guards, cleaners, and health information staff. Health facilities were categorised based on their level of care: primary (polyclinics), secondary (district and mission hospitals), tertiary (provincial hospitals) and quaternary (central specialised group of hospitals). These facilities were either owned by local authority, the central government, or faith-based organisations. Past medical history of co-morbidities was coded as i) none ii) one or iii) two or more co-morbidities. Co-morbidities which were ascertained through self-report included: HIV, asthma, chronic lung disease, cancer, diabetes, hypertension, cardiovascular disease, and chronic kidney disease. Body mass index (BMI) was calculated using weight and height. Healthcare workers with a BMI <18.5, 18.5–24.9, 25–29.9, and >30 were categorised as underweight, healthy, overweight, and obese respectively.

In-depth interviews were audio-recorded, transcribed, and translated by trained research assistants. During the interview, research assistants took field notes and wrote interview summaries at the end of the day. Transcripts and other qualitative data (i.e., field notes and interview summaries) were imported into the qualitative data analysis software NVivo 12. Within an overarching grounded theory approach, [30] we used thematic analysis [29] that ran synchronously with, and subsequent to, the collection of data. Interim analysis of an initial set of transcripts to identify patterns within the data, based on which initial themes and working hypotheses were generated. Hypotheses generated from this interim analysis were fed back into the topic guide and subsequent interviews to refine and, where appropriate, change our working hypotheses. Working iteratively back and forth between analysis and data collection, we worked towards progressively broader and more encompassing themes to explain and theorise findings. Quantitative findings were triangulated with the themes emerging from the qualitative data throughout the analysis process to create meaning of the findings. The overall aim of this bottom-up analytic process was to produce a robust, contextual understanding and interpretation of the vaccine uptake among healthcare workers in Zimbabwe.

Ethical approval

Ethical approval was obtained from the Medical Research Council Zimbabwe (MRCZ/A/2627); the Biomedical Research and Training Institute and the London School of Hygiene and Tropical Medicine ethics committees (22514). For healthcare workers accessing the health check service and responding to the quantitative questionnaire, verbal informed consent was obtained. The Medical Research Council Zimbabwe waived the necessity for a written informed consent to facilitate access to the service. Written informed consent was obtained from all participants for participation in the in-depth interviews.

Inclusivity in global research

Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in S1 Checklist.

Results

Reported vaccine uptake among health care workers

A total of 3,086 healthcare workers from 43 health facilities accessed the service during the study period, half of which worked at facilities in Harare and Bulawayo provinces (Table 1). Three-quarters (2,339/3,086, 75.8%) were women, and median age was 37 (IQR: 28–46) years. The majority of healthcare workers had clinical roles (2,979/3,086, 96.5%). A total of 931 (30.2%) healthcare workers had one or more known chronic diseases, and 64.1% (1,978/3,086) were either overweight or obese and about a third (1,086/3,086, 35.2%) worked at a government-owned institution. Past SARS-CoV-2 infections were reported by 1,119 (36.3%) healthcare workers.

Table 1. Baseline characteristics of healthcare workers accessing the occupational health services stratified by time of COVID-19 vaccination.

Variables Early vaccination (Feb 21—June 21) N (%) Late vaccination (After June 21) N (%) Non-vaccinated, N (%)
Total 1,535 1,451 100
Sex Male (n = 745) 382 (51.3) 342 (45.9) 21 (2.8)
Female (n = 2,339) 1,152 (49.3) 1,108 (47.4) 79 (3.4)
Age (years) < 30 (n = 944) 321 (34.0) 573 (60.7) 50 (5.3)
30–40 (n = 914) 453 (49.6) 428 (46.8) 33 (3.6)
> 40 (n = 1,226) 760 (62.0) 449 (36.6) 17 (1.4)
Role Clinical (n = 2,979) 1,478 (49.6) 1,402 (47.1) 99 (3.3)
Non-clinical (n = 105) 56 (53.3) 48 (45.7) 1 (1.0)
Years at current role < 1 (n = 574) 113 (19.7) 426 (74.2) 35 (6.1)
1–5 (n = 1,225) 646 (52.7) 544 (44.4) 35 (2.9)
6–10 (n = 478) 284 (59.4) 183 (38.3) 11 (2.3)
> 10 (n = 807) 491 (60.8) 297 (36.8) 19 (2.4)
Number of known comorbidities None (n = 2,153) 977 (45.4) 1,101 (51.1) 75 (3.5)
1 (n = 770) 454 (59.0) 297 (38.6) 19 (2.5)
> 1 (n = 161) 103 (64.0) 52 (32.3) 6 (3.7)
History of SARS-CoV-2 infection Yes (n = 1,119) 587 (52.5) 503 (45.0) 29 (2.6)
No (n = 1,967) 948 (48.2) 948 (48.2) 71 (3.6)
Body mass index Underweight (n = 82) 33 (40.2) 46 (56.1) 3 (3.7)
Healthy (n = 1,015) 452 (44.5) 517 (50.9) 46 (4.5)
Overweight (n = 930) 475 (51.1) 434 (46.7) 21 (2.3)
Obese (n = 1,048) 570 (54.4) 448 (42.7) 30 (2.9)
Highest level of education O-levels (n = 1,293) 625 (48.3) 618 (47.8) 50 (3.9)
A-levels (n = 362) 138 (38.1) 213 (58.8) 11 (3.0)
Diploma (n = 1,057) 569 (53.8) 454 (43.0) 34 (3.2)
University (n = 372) 202 (54.3) 165 (44.4) 5 (1.3)
Type of facility Primary (n = 950) 528 (55.6) 380 (40.0) 42 (4.4)
Secondary (n = 1,187) 567 (47.8) 593 (50.0) 27 (2.3)
Tertiary (n = 770) 323 (41.9) 421 (54.7) 26 (3.4)
Quaternary (n = 155) 98 (63.2) 52 (33.5) 5 (3.2)
Administrative authority Local (n = 1,603) 878 (54.8) 670 (41.8) 55 (3.4)
Government (n = 1,086) 481 (44.3) 569 (52.4) 36 (3.3)
Mission or private (n = 391) 172 (44.0) 210 (53.7) 9 (2.3)
Province Harare (n = 959) 536 (55.9) 381 (39.7) 42 (4.4)
Bulawayo (n = 467) 244 (52.2) 211 (45.2) 12 (2.6)
Mashonaland East (n = 271) 81 (29.9) 182 (67.2) 8 (3.0)
Mashonaland West (n = 275) 117 (42.5) 144 (52.4) 14 (5.1)
Mashonaland Central (n = 161) 60 (37.3) 96 (59.6) 5 (3.1)
Masvingo (n = 165) 60 (36.4) 98 (59.4) 7 (4.2)
Manicaland (n = 158) 91 (57.6) 65 (41.1) 2 (1.3)
Midlands (n = 164) 71 (43.3) 90 (54.9) 3 (1.8)
Matabeleland South (n = 331) 184 (55.6) 142 (42.9) 5 (1.5)

⁑ = Row percentages

Almost all healthcare workers (2,986/3,086, 96.8%) reported having received at least one dose of COVID-19 vaccine, and most had received two doses (2,905/2,986, 97.3%). Half of the healthcare workers received their first dose before the 30th of June 2021 (1,535/2,986, 51.4%). Sinopharm (1,747/2,986, 58.5%) was the most frequently administered vaccine followed by Sinovac (1,059/2,986, 35.5%); the remaining 2% had received Sputnik V or were not sure of the vaccine they had received.

In the multivariable model, age, number of years in current role, administrative authority, and province were associated with receiving the vaccine late. Healthcare workers of older age (aOR: 0.48, 95% CI: 0.37–0.62) were less likely to receive the vaccine late. Clients who were working in their current role for less than one year (aOR: 4.01, 95% CI: 3.12–5.14) and those working at a mission or private institution (aOR: 2.32, 95% CI: 1.54–3.49), however, were more likely to receive the vaccine late. There was evidence of association between province where the health facility was located and time of vaccine uptake, though it varied by province (Table 2).

Table 2. Multivariable logistic regression investigating the association between client characteristics and receiving the vaccine late (n = 2,986).

Variables aOR 95% CI p-value
Sex Male - 0.49
Female 1.07 0.88–1.30
Age (years) < 30 - < 0.001
30–40 0.74 0.58–0.94
> 40 0.48 0.37–0.62
Years at current role < 1 4.01 3.12–5.14 < 0.001
1–5 -
6–10 0.94 0.74–1.20
> 10 0.99 0.79–1.24
History of SARS-CoV-2 infection Yes 0.80 0.50–1.29 0.86
No -
Body mass index Underweight 1.00 0.60–1.65 0.93
Healthy -
Overweight 1.03 0.84–1.27
Obese 1.01 0.81–1.25
Highest level of education O-levels - 0.09
A-levels 0.92 0.69–1.22
Diploma 0.86 0.71–1.03
University 0.81 0.63–1.05
Administrative authority Local - < 0.001
Government 0.85 0.63–1.15
Mission or private 2.32 1.54–3.49
Province Harare - < 0.001
Bulawayo 0.89 0.68–1.16
Mashonaland East 3.21 2.10–4.91
Mashonaland West 1.75 1.25–2.46
Mashonaland Central 2.79 1.74–4.46
Masvingo 0.93 0.54–1.61
Manicaland 1.04 0.65–1.67
Midlands 1.33 0.83–2.14
Matabeleland South 0.59 0.41–0.85

p-value was derived using a likelihood ratio test.

Abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval

Factors influencing vaccine uptake

Please note we have included appropriate themes, codes, and additional quotes in S2 Table.

(Mis)Information

Participants generally felt that the government had run an effective information campaign using radio, television, billboards, and banners. The information provided, they felt, was reliable, accurate, and easy to understand, and included messages encouraging the population to get vaccinated. However, it was highlighted that information was not always communicated in all languages, which impacted the accessibility of information.

In terms of information I think they have done pretty well, maybe they will just put in all languages because at times you would go to get news and you see it will be written in Shona only, there is no Ndebele poster. It’s not everyone who will understand what they are saying. So, they should just try and put it in all languages so that everyone in their respective places they read and understand.” (Clinician, Late Receiver, Matabeleland North).

Additionally, information about accessing the vaccine while breastfeeding, during pregnancy, and if HIV-positive was not consistent, especially at the start of the vaccination campaign.

I think the message wasn’t so clear [from the government], people had so many questions about the vaccine. Like who is eligible for the vaccines, for example at first it was said pregnant women are not supposed to be vaccinated. Like as healthcare workers you are just telling people that pregnant women should not be vaccinated but after some time, they say pregnant women are eligible. Already people are having some sort of confusion and others are still holding on to that old information. And I think that information they gave us it wasn’t really enough.” (Clinician, Early Receiver, Bulawayo)

This was supported by the quantitative data (Fig 2) showing that the most frequently reported reason for not being vaccinated was pregnancy, breastfeeding or trying to conceive (47/98, 48%), followed by fear of side effects (12/98, 12.2%).

Fig 2. Bar graph showing reasons for no COVID-19 vaccination among healthcare workers (N = 100) based on the 5Cs of hesitancy model [31].

Fig 2

While some participants felt that the government had provided reliable information about the vaccines, most participants reported the internet and social media being their main sources of information. However, they acknowledged that these sources also spread false information. It was felt that misinformation was an important factor preventing or hindering people to get vaccinated.

That social media news, that maybe today 100 people got vaccinated and they all died or 3 days after vaccination they died, or they reacted badly or something. Very much impact it had because I delayed getting my vaccine for so long to an extent that I got my vaccination by the time when the government was like, if you don’t get vaccinated you will be kicked out of work or school or something.” (Clinician, Late Receiver, Matabeleland South)

Religion

According to respondents, religion is critically important for many people in Zimbabwe and religious leaders were actively involved in the vaccination campaign. Almost three quarters of healthcare workers (2,295/3,086, 74%) believed that their community leaders and/or religious leaders would want them to get vaccinated. There was no difference in the proportion of healthcare workers who responded affirmatively to having received the vaccine by age, sex, province, or professional role.

However, despite healthcare workers reporting quantitatively that their religious leaders had no reservations about or were in favor of vaccinations, the qualitative data revealed that some churches did in fact have reservations:

For some churches they are in between because they could not reverse what was being said officially, they would say go and get vaccinated but deep-down people would be saying we can’t get a vaccine that we don’t understand” (Clinician, Late Receiver, Harare).

Some healthcare workers felt that select church leaders did not encourage vaccination and were rather negative towards COVID-19 vaccines. Participants reported that some churches, specifically the Pentecostal churches and the Apostolic, claimed that their followers “…will be protected by the Holy Spirit. (Clinician, Early Receiver, Harare). One participant said that they had heard church leaders preaching that:

…the vaccine is for the triple six, so much so that even up to now, some people have not taken up the vaccine, because they think it’s satanism” (Clinician, Late Receiver, Harare).

Important myths included the risk of death two years after receiving the vaccine, an association between COVID-19 vaccines and satanism, and the perception that COVID-19 vaccines were the “mark of the beast”. One respondent reported that he had been led to believe that:

…you die after 2 years. They were saying the injection has a period of survival just for 2 years. Then you die after 2 years that is what people were saying” (Non-clinician, Early Receiver, Harare).

Perceptions of vaccine efficacy and safety

Generally, healthcare workers perceived the vaccine as ‘moderately safe’ (1,088/3,086, %) or ‘very safe’ (1,665/3,086, %). Older HCWs (≥40 years) were more likely to perceive COVID-19 vaccines as very safe (735/1,226, 60%) compared to those <40 years old (929/1,858, 50%).

When probing for detail, healthcare workers voiced some concerns regarding vaccine safety, specifically due to side effects. While none of the interviewed healthcare workers had experienced side effects themselves, they said that some of their friends, colleagues, and family members had experienced symptoms which they believed were due to vaccination.

[L]ike there is this nurse that I saw, she had a reaction; she had some sort of funny reaction as if it was like burns. I don’t know but she had a reaction, so that on its own is a push factor. She had some complications, and she was admitted, that’s a push factor, when people tell you that they have reacted”. (Clinician, Early Receiver, Bulawayo)

The origin (China) of the vaccine was also raised as a cause of concern, specifically because China was the origin of the pandemic and due to theories that the pandemic was man-made.

The fact that our vaccine came from China and yet the disease itself, started in China. It seemed like the vaccine coming from China, there are motives to kill us all. That’s how it seemed, why did the vaccine come from China?. From everyone, everyone was just concerned about how people died in China and how the disease started. Then it said they have found a vaccine, yet the disease was from there. There were stories that the disease was man made.” (Clinician, Late Receiver, Manicaland).

Reports of break-through infections further decreased the confidence into the vaccine. Participants questioned the effectiveness of the vaccine:

Yes, after being vaccinated. I was talking to one nurse who was saying she wasn’t feeling well. I hadn’t seen her in a long time, and I asked her where she had gone and she said she had been sick, COVID-19. I asked her if she had been vaccinated and she said she was vaccinated, you could see that she was doubting the vaccine. And there are some who were never vaccinated but up to now they have never been diagnosed of COVID-19” (Clinician, Late Receiver, Harare).

SARS-CoV-2 infection an occupational risk

The risk of severe infection and death was seen as a real possibility and motivation for taking up the vaccine. Healthcare workers felt that they were at a heightened risk of contracting the infection because of the nature of their work. The vaccine was seen as an extra layer of protection (an alternative or additional “personal protective equipment”) in situations where there was a breakdown of infection prevention and control because people around them were not adhering to prevention and control measures.

The risk of getting COVID-19 here is very high. As individual who works in the outpatient’s department. We are the ones that welcome patients. We are the face of the hospital that receive patients even if they do then go to the wards, but patients come through our hands first, whether positive or negative.” (Clinician, Late Receiver, Manicaland)

And then pull factors that thing that you are working with people that are suffering from COVID-19. And you have nothing to protect yourself, you just feel that you have to go and get vaccinated.” (Clinician, Early Receiver, Bulawayo)

Risk of infection was perceived to be omnipresent. Healthcare workers felt unsafe even away from work because of transmission in the community. What put them at additional risk in the community (over and above other people) was that community members frequently visited their homes to seek health advice (because they were healthcare workers).

People with chronic disease such as HIV and diabetes felt even more vulnerable and hence were anxious to get vaccinated as early as possible.

I can easily contract it because of my condition, that I am HIV positive, so we are at risk of contracting a lot of diseases. Because our immune system is weak and is unable to fight strong infections. So that risk makes me afraid that I can contract COVID-19” (Non-clinician, Early Receiver, Harare).

Employment and access to services

Some institutions, especially those run by the government, mandated their employees to be vaccinated. In addition, statements were made that unvaccinated people would not be paid or denied entry into workplaces. Some people accessed vaccination because of work requirements.

A lot of people are being pushed [into being vaccinated] by work because a lot of institutions are saying if you are not vaccinated then we won’t hire you, so that ends up pushing people.” (Non-clinician, Early Receiver, Harare).

“Yes, I have seen people come saying ‘I work for a private company. So, they are saying they want everyone vaccinated. If you are not vaccinated, you won’t work.” (Clinician, Early Receiver, Bulawayo).

Also, it was felt that vaccination was mandatory to access various services and institutions. Such institutions included hospitals, churches, and subsidised transport. Some believed that “nowadays you cannot do anything without being vaccinated,” (Clinician, Early Receiver, Harare).

Some of the push factors are that maybe they say that if you are not vaccinated you will not board the ZUPCO buses or that you won’t be able to enter into the supermarket. Or you won’t be able to go to the bar or you won’t be able to travel from Harare to Bulawayo or Harare to Mutare. Without the vaccination card I feel these are some of the things that will influence people to get vaccinated” (Non-clinician, Early Receiver, Harare).

Other people’s experiences and recommendation for vaccination

More cautious participants initially delayed vaccination to observe what would happen to those who were vaccinated. The experience of other co-workers, particularly seniors (managers and supervisors), friends, and relatives and their encouragements had great influence on vaccine uptake.

So, I was one of those people that wanted to wait and see what happens to those that have been vaccinated in 5 years. But because seeing that those vaccinated were not having any side effects I just decided to be vaccinated” (Clinician, Late Receiver, Mashonaland Central).

“Because most of my peers have been vaccinated and they have been encouraging me to get vaccinated. So, if I make that decision, they will be happy.” (Clinician, Never Vaccinated, Mashonaland Central).

With vaccines becoming more widely available and the number of vaccinations administered increasing, people were less reluctant to receive their vaccine: “because they discovered nothing [wrong] was going on with them [the vaccinated]”, (Clinician, Late Receiver, Harare).

Even though some healthcare workers were initially reluctant and based their decisions to get vaccinate on first observing the outcomes of their vaccinated clients, at the time of the survey a high proportion of healthcare workers (2,855/3,086, 93%) said that they would recommend COVID-19 vaccine to eligible patients. About three quarters of the healthcare workers (2,270/3,086, 74%) thought most of their close family members and friends would want them to get a COVID-19 vaccine. One healthcare worker said:

I would also recommend. I think because it didn’t give me any problems and maybe the fact that from what I have been hearing that, if you are not vaccinated and if you catch COVID it might be less severe. So, I would recommend.” (Clinician, Early Receiver, Bulawayo).

Vaccine availability and access

According to healthcare workers, provision of vaccine services at health facilities prolonged waiting times for vaccination and other services. Vaccine stocks were sometimes running low and thus people who attended the service for their first shot were turned away as available vaccines were reserved for those attending to receive the second vaccine dose. Though vaccines were eventually delivered to all provinces, initially vaccines were only available in selected approved health facilities in Harare and Bulawayo.

It’s not always available, sometimes it runs out. Sometimes they say they have run out of first dose; they only have second dose so its vice versa.” (Clinician, Late Receiver, Harare)

“There was a time when the first dose was not available, but the second was always there. Some time back at the beginning it was available, but there came a time when it was no longer available.” (Clinician, Early Receiver, Harare).

However as for healthcare workers themselves, very few reported that the reason for not getting vaccinated were logistical reasons such as long waiting time (2% [n = 2/98]) and vaccine stocks (1% [n = 1]).

Discussion

In this mixed-method study we explored COVID-19 vaccine uptake among healthcare workers in Zimbabwe. Understanding vaccine uptake and the reasons behind it, as well as remaining concerns that were not adequately addressed, is important for developing new vaccine approaches. With WHO declaring COVID-19 as no longer constituting a global health emergency, vaccine strategies have changed accordingly. Nonetheless, in these new strategies healthcare workers remain a key target population, with the Africa CDC’s proposed “100-100-70” targeting the vaccination of 100% of healthcare workers [18]. Achieving these ambitious targets will require careful appraisal of successes, challenges, and opportunities for improved vaccination coverage.

The remarkably high (>97%) prevalence of self-reported COVID-19 vaccine uptake in our study is in stark contrast to other studies from Africa which reported COVID-19 vaccine coverage of 33% and 90% in two settings in Nigeria, respectively, 49% in Somalia, 62% in Ethiopia, 69% in Uganda [3236]. The main reasons for not being vaccinated in these studies were safety concerns, fear of side effects, and non-availability of the vaccine. A more granular analysis of our results revealed that time of uptake (i.e., whether a person received a vaccine ‘early’ or ‘late’) was influenced by geographical location, known chronic conditions, level of education, and professional role. However, overall, there were no clear demographic or behavioural predictors of receiving the vaccine ‘early’ or ‘late’ above the patterns of availability and access within the country. For instance, the Bulawayo and Harare provinces, the primary ‘hotspots’ of the epidemic, received the vaccine first [37], largely due to vaccine supply and availability, which likely influenced who got the vaccine early or late among provinces and hence among the healthcare workers participating in this study. This country-level distribution strategy was in itself shaped by the wider geopolitical situation, notably global vaccine inequality, bilateral arrangement with China, and erratic vaccine supply [38]. Despite high overall rates of vaccination, these inequities and access-related challenges were evidently at play in our research within the Zimbabwean context.

Beyond the broader patterns of access, availability, and distribution, we identified several socio-behavioural influencers that contributed to a comparatively high vaccine uptake as identified by other studies elsewhere [38, 39]. First, many of the healthcare workers felt that the vaccination campaign was effective and paired with well-designed information, education, and communication. Good communication from formal channels helped alleviate concerns and counter misinformation. This perception was not without exception or reservations, however, as one of the main reasons for not getting vaccinated among healthcare workers was pregnancy, suggesting that there were key gaps and inconsistencies in information being provided. Information was also noted as not provided in Zimbabwean local languages, which may not have impacted healthcare workers uptake (who are trained in English) but may have impact on uptake among the general population.

Moreover, concerns about the vaccine were certainly present among healthcare workers. Participants expressed concerns about the vaccine’s origin, the speed taken to develop which led to safety and efficacy concerns. These concerns were clearly amplified by rumours and misinformation that were rife during the pandemic, as highlighted by many of our participants. Studies elsewhere have shown the influence of COVID-19 misinformation on public confidence, leading to vaccine scepticism [39, 40]. In our study, social media and religious leaders were considered to be important opinion leaders and spreaders of (mis)information among the community. The wide influence of religious leaders highlights the importance of engaging them in health-related matters and specifically on vaccinations. While our findings show that misinformation did not hugely affect the vaccine uptake among healthcare workers as in other settings [39, 41], these concerns need to be taken seriously in future risk communication and community engagement (RCCE) strategies. Healthcare workers are considered a source of trusted information for the community and hence gatekeepers to high vaccination coverage of the general population.

A second main reason behind high uptake in our study is explained by healthcare workers’ occupational risk perception. In a study which examined the relationship between risk perception, vaccine trust, and vaccine uptake the authors found that perceived risk of SARS-CoV-2 infection increased COVID-19 vaccination by 1.6 times [42]. In our study, healthcare workers felt vulnerable to SARS-CoV-2 infections and because they believed that vaccines were generally safe, they then got vaccinated. In the absence of adequate personal protective equipment, healthcare workers viewed COVID-19 vaccination as an extra layer of protection. Generally, those who were objectively at higher risk of severe disease (such as older people, people with obesity and/or co-morbidities) were more likely to be vaccinated earlier. This may be due to their own perceived higher risk, or it may be due to initial prioritisation of these at-risk groups among healthcare workers and also an effect of the RCCE campaign.

Finally, and perhaps most influential of all, mandatory vaccination policies, though not stringently applied, influenced the vaccine uptake among healthcare workers in Zimbabwe. ‘Mandatory vaccination’ is defined as ‘a policy that establishes a requirement that an individual be vaccinated based on their status or their eligibility to access societal or governmental benefits’ [43]. Mandatory vaccination can be effective in increasing uptake as found in other settings such as Somalia, and Uganda [33, 34]. However, such a strategy has the potential to undermine trust of both the vaccine but also the authority mandating vaccination. While stringent lockdowns and mandatory vaccination may have been acceptable during a time of intense COVID-19 transmission, high infection and case-fatality rates, such measures are unlikely to be acceptable in the post COVID-19 emergency era. Studies on COVID-19 vaccine mandatory have shown resistant perception about mandating the vaccine [44, 45]. Mandatory vaccination most certainly does not solve often quite legitimate concerns people may have about new vaccines and treatment but may exacerbate them [46]. Therefore, mandating vaccination needs to be carefully balanced with other interventions. It might be noted that historically, Zimbabwe achieved high vaccine uptake across different vaccination programs including Expanded Program on Immunization for children, typhoid conjugate vaccine (84.5% for children and adults and human papilloma virus vaccine (88–94%) for young adults [47, 48]. Mandatory vaccine policies were not in place for these other vaccine-preventable diseases.

As our study and several others have shown [4952], healthcare workers are not simply passive participants of a vaccination campaign, as seen by their calculated risk assessments and astute socio-political observations. Given their centrality to current and future vaccine policy, their active involvement in the development of strategies is key, especially in addressing legitimate concerns which can be packaged in RCCE activities. Increasing vaccine choices and transparency on adverse effects after immunization through surveillance is likely to address healthcare workers’ legitimate concerns and anxieties. Beyond healthcare workers, misinformation disseminated on social media should be addressed proactively by working with influencers such as religious leaders and public figures.

The strengths of this study lie in the use of a mixed-method approach investigating self-reported vaccine uptake and associated reasons. Our use of both qualitative and quantitative methods allowed us to combine the strengths of deductive and inductive reasoning, while offsetting the limitations of using exclusively one approach. This complementary approach enabled us to produce a robust and reliable, but also nuanced and contextual understanding of vaccine uptake among healthcare workers in Zimbabwe. The sample size was large both with regards to the number of healthcare workers included and the number of health facilities, with the latter including a diverse range of health facilities from tertiary to primary level and across different provinces. The limitations include that vaccination was self-reported and not verified by checking vaccination cards and thus may have been subject to social desirability (by which healthcare workers could have responded in a generally positive way which conforms to their profession) and/or recall bias (specifically the date of vaccination). Also, healthcare workers were self-selected from those who came forward to access the health check-up service. This may have introduced selection bias as those healthcare workers who took up the health check service may have been more health conscious and thus more likely to be vaccinated.

Conclusion

In conclusion, vaccine uptake among healthcare workers in Zimbabwe is high despite the limited vaccine choices, misinformation, hesitancy, and health systems challenges. The key factors positively affecting uptake were a generally well organised information and communication campaign (with certain limitations) and occupational risk perception coupled with ‘mandatory vaccination’. (Mis)information on social media and through religious leaders as well as vaccine-related logistics were also thought to be important. Active engagement of healthcare workers in vaccine strategy is crucial for understanding current concerns and for developing context-sensitive strategies that address remaining concerns of healthcare workers and wider population.

Supporting information

S1 Checklist. PGPH-D-23-01351 inclusivity questionnaire.

The form has been filled in as per the Plos Global Health inclusivity requirements.

(DOCX)

S1 Table. Multivariable logistic regression investigating the association between client characteristics and receiving the vaccine late or never receiving the vaccine (n = 1,551).

The table illustrates the results of a multivariable logistic regression sensitivity analysis. The p-value was derived using a likelihood ratio test and the abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval.

(DOCX)

S2 Table. Healthcare workers COVID-19 vaccine uptake emerging themes, codes, and additional quotes.

The table has three columns showing themes, codes, and relevant supporting quotes that emerged from the qualitative thematic data analysis.

(DOCX)

Data Availability

Data are available open access via London School of Hygiene and Tropical Medicine (LSHTM) Data Compass https://doi.org/10.17037/DATA.00003679.

Funding Statement

This work was supported by the Global Public Health strand of the Elizabeth Blackwell Institute for Health Research, funded under the University of Bristol’s QR GCRF strategy (ref:H100004-148) as well as support from Sheffield and Oxford QR-GCRF funds. It was supported by UK aid from the UK government (FCDO) (ref 668 303), and by funding from the government of Canada. The views expressed do not necessarily reflect the policies of the respective governments. RAF is funded by a Wellcome Trust Senior Fellowship (206316_Z_17_Z). IDO has received funding through the Wellcome Trust Clinical PhD Programme awarded to the London School of Hygiene & Tropical Medicine (grant number 203905/Z/16/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tinotenda Taruvinga is supported by the Fogarty International Centre of the National Institutes of Health (NIM; Bethesda, Maryland, MD, USA) under Award Number D43 TW009539. The content therein is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

References

  • 1.Jara A, Undurraga EA, Zubizarreta JR, González C, Pizarro A, Acevedo J, et al. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study. Lancet Glob Health. 2022;10: e798–e806. doi: 10.1016/S2214-109X(22)00112-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021; n1088. doi: 10.1136/bmj.n1088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Self WH, Tenforde MW, Rhoads JP, Gaglani M, Ginde AA, Douin DJ, et al. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions—United States, March–August 2021. MMWR Morb Mortal Wkly Rep. 2021;70: 1337–1343. doi: 10.15585/mmwr.mm7038e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mutombo PN, Fallah MP, Munodawafa D, Kabel A, Houeto D, Goronga T, et al. COVID-19 vaccine hesitancy in Africa: a call to action. Lancet Glob Health. 2022;10: e320–e321. doi: 10.1016/S2214-109X(21)00563-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11: 427–440. doi: 10.18683/germs.2021.1280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Murewanhema G, Musuka G, Denhere K, Chingombe I, Mapingure MP, Dzinamarira T. The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the Programme. Vaccines. 2022;10: 1–11. doi: 10.3390/vaccines10020262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ogunleye OO, Godman B, Fadare JO, Mudenda S, Adeoti AO, Yinka-Ogunleye AF, et al. Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future. Vaccines. 2022;10: 1553. doi: 10.3390/vaccines10091553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tlotleng N, Cohen C, Made F, Kootbodien T, Masha M, Naicker N, et al. COVID-19 hospital admissions and mortality among healthcare workers in South Africa, 2020–2021. IJID Reg. 2022;5: 54–61. doi: 10.1016/j.ijregi.2022.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Peterson CJ, Lee B, Nugent K. COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review. Vaccines. 2022;10: 948. doi: 10.3390/vaccines10060948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ferland L, Carvalho C, Gomes Dias J, Lamb F, Adlhoch C, Suetens C, et al. Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020–January 2021. J Hosp Infect. 2022;119: 170–174. doi: 10.1016/j.jhin.2021.10.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sarkar MK, Babu TA, Dey S, Upparakadiyala R, Lingaiah P, Venugopal V. Front-Line vs Second-Line Healthcare Workers: Susceptibility Prediction to COVID-19 Infection in a Tertiary Care Teaching Institute. Cureus. 2023;15. doi: 10.7759/cureus.37915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, et al. COVID-19 Vaccine Uptake among Healthcare Workers: A Systematic Review and Meta-Analysis. Vaccines. 2022;10: 1637. doi: 10.3390/vaccines10101637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alame M, Kaddoura M, Kharroubi S, Ezzeddine F, Hassan G, Diab El-Harakeh M, et al. Uptake rates, knowledge, attitudes, and practices toward seasonal influenza vaccination among healthcare workers in Lebanon. Hum Vaccines Immunother. 2021;17: 4623–4631. doi: 10.1080/21645515.2021.1948783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sevidzem Wirsiy F, Nkfusai NC, Ebot Ako-Arrey D, Kenfack Dongmo E, Titu Manjong F, Nambile Cumber S. Acceptability of COVID-19 Vaccine in Africa. Int J Matern Child Health AIDS IJMA. 2021;10: 134–138. doi: 10.21106/ijma.482 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Karafillakis E, Dinca I, Apfel F, Cecconi S, Wűrz A, Takacs J, et al. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016;34: 5013–5020. doi: 10.1016/j.vaccine.2016.08.029 [DOI] [PubMed] [Google Scholar]
  • 16.McAbee L, Tapera O, Kanyangarara M. Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study. Vaccines. 2021;9: 1109. doi: 10.3390/vaccines9101109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. [cited 29 May 2023]. Available: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic [Google Scholar]
  • 18.Acceleration and Integration: A Progressive Approach for Saving Lives and Livelihoods. In: Africa CDC [Internet]. [cited 29 May 2023]. Available: https://africacdc.org/news-item/acceleration-and-integration-a-progressive-approach-for-saving-lives-and-livelihoods/
  • 19.Kavenga F, Rickman HM, Chingono R, Taruvinga T, Marembo T, Manasa J, et al. Comprehensive occupational health services for healthcare workers in Zimbabwe during the SARS-CoV-2 pandemic. PLOS ONE. 2021;16: e0260261. doi: 10.1371/journal.pone.0260261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Maulani N, Nyadera IN, Wandekha B. The generals and the war against COVID-19: The case of Zimbabwe. J Glob Health. 10: 020388. doi: 10.7189/jogh.10.020388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tom T, Chipenda C. COVID-19, Lockdown and the Family in Zimbabwe. J Comp Fam Stud. 2020;51: 288–300. doi: [DOI] [Google Scholar]
  • 22.Banda Chitsamatanga B, Malinga W. ‘A tale of two paradoxes in response to COVID-19’: Public health system and socio-economic implications of the pandemic in South Africa and Zimbabwe. Serpa S, editor. Cogent Soc Sci. 2021;7: 1869368. doi: 10.1080/23311886.2020.1869368 [DOI] [Google Scholar]
  • 23.Mavhunga C. Zimbabwe Rolls Out Coronavirus Vaccination Program. In: VOA [Internet]. 18 Feb 2021. [cited 8 Jun 2023]. Available: https://www.voanews.com/a/covid-19-pandemic_zimbabwe-rolls-out-coronavirus-vaccination-program/6202235.html [Google Scholar]
  • 24.Independent T. Zimbabwe to start administering booster doses as omicron variant sets in. In: The Independent Uganda: [Internet]. 4 Dec 2021 [cited 8 Jun 2023]. Available: https://www.independent.co.ug/zimbabwe-to-start-administering-booster-doses-as-omicron-variant-sets-in/
  • 25.WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. [cited 8 Jun 2023]. Available: https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations
  • 26.Zimbabwe authorises Sputnik V, Sinovac coronavirus vaccines for emergency use. Reuters. 10 Mar 2021. Available: https://www.reuters.com/article/uk-health-coronavirus-zimbabwe-vaccine-idUSKBN2B20K3. Accessed 8 Jun 2023. [Google Scholar]
  • 27.Reuters. Zimbabwe approves J&J COVID-19 vaccine for emergency use. Reuters. 28 Jul 2021. Available: https://www.reuters.com/business/healthcare-pharmaceuticals/zimbabwe-approves-jj-covid-19-vaccine-emergency-use-2021-07-28/. Accessed 8 Jun 2023. [Google Scholar]
  • 28.Ministry of Health and Child Care—Latest Updates. [cited 29 May 2023]. Available: http://www.mohcc.gov.zw/
  • 29.Aldiabat K, Le Navenec C-L. Data saturation: The mysterious step in grounded theory methodology. Qual Rep. 2018;23: 245–261. doi: 10.46743/2160-3715/2018.2994 [DOI] [Google Scholar]
  • 30.Charmaz K. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis. SAGE; 2006. [Google Scholar]
  • 31.Razai MS, Oakeshott P, Esmail A, Wiysonge CS, Viswanath K, Mills MC. COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors. J R Soc Med. 2021;114: 295–298. doi: 10.1177/01410768211018951 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Agha S, Chine A, Lalika M, Pandey S, Seth A, Wiyeh A, et al. Drivers of COVID-19 Vaccine Uptake amongst Healthcare Workers (HCWs) in Nigeria. Vaccines. 2021;9: 1162. doi: 10.3390/vaccines9101162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dahie HA, Mohamoud JH, Adam MH, Garba B, Dirie NI, Sh. Nur MA, et al. COVID-19 Vaccine Coverage and Potential Drivers of Vaccine Uptake among Healthcare Workers in SOMALIA: A Cross-Sectional Study. Vaccines. 2022;10: 1116. doi: 10.3390/vaccines10071116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Akech GM, Kanyike AM, Nassozi AG, Aguti B, Nakawuki AW, Kimbugwe D, et al. COVID-19 Vaccination Uptake and Self-Reported Side Effects among Healthcare Workers in Mbale City Eastern Uganda. Infectious Diseases (except HIV/AIDS); 2022. Jul. doi: 10.1101/2022.07.11.22277490 [DOI] [Google Scholar]
  • 35.Rikitu Terefa D, Shama AT, Feyisa BR, Ewunetu Desisa A, Geta ET, Chego Cheme M, et al. COVID-19 Vaccine Uptake and Associated Factors Among Health Professionals in Ethiopia. Infect Drug Resist. 2021;14: 5531–5541. doi: 10.2147/IDR.S344647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Abubakar AT, Suleiman K, Ahmad SI, Suleiman SY, Ibrahim UB, Suleiman BA, et al. Acceptance of COVID-19 vaccine among healthcare workers in Katsina state, Northwest Nigeria. Public and Global Health; 2022. Mar. doi: 10.1101/2022.03.20.22272677 [DOI] [Google Scholar]
  • 37.Zimbabwe N. Bulawayo Ready To Kick-Start Vaccination After Covid-19 Jab Delivery. In: NewZimbabwe.com [Internet]. 20 Feb 2021. [cited 3 Jun 2023]. Available: https://www.newzimbabwe.com/bulawayo-ready-to-kick-start-vaccination-after-covid-19-jab-delivery/ [Google Scholar]
  • 38.Schryer-Roy A-M, Lenard K. New Study Shows Rich Country Shopping Spree for COVID-19 Vaccines Could Mean Fewer Vaccinations for Billions in Low-Income Countries.
  • 39.Ennab F, Babar MS, Khan AR, Mittal RJ, Nawaz FA, Essar MY, et al. Implications of social media misinformation on COVID-19 vaccine confidence among pregnant women in Africa. Clin Epidemiol Glob Health. 2022;14: 100981. doi: 10.1016/j.cegh.2022.100981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5: 337–348. doi: 10.1038/s41562-021-01056-1 [DOI] [PubMed] [Google Scholar]
  • 41.Skafle I, Nordahl-Hansen A, Quintana DS, Wynn R, Gabarron E. Misinformation About COVID-19 Vaccines on Social Media: Rapid Review. J Med Internet Res. 2022;24: e37367. doi: 10.2196/37367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wang J, Lu X, Lai X, Lyu Y, Zhang H, Fenghuang Y, et al. The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study. Vaccines. 2021;9: 191. doi: 10.3390/vaccines9030191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Blank C, Gemeinhart N, Dunagan WC, Babcock HM. Mandatory employee vaccination as a strategy for early and comprehensive health care personnel immunization coverage: Experience from 10 influenza seasons. Am J Infect Control. 2020;48: 1133–1138. doi: 10.1016/j.ajic.2020.01.015 [DOI] [PubMed] [Google Scholar]
  • 44.Kozak A, Nienhaus A. COVID-19 Vaccination: Status and Willingness to Be Vaccinated among Employees in Health and Welfare Care in Germany. Int J Environ Res Public Health. 2021;18: 6688. doi: 10.3390/ijerph18136688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Giannakou K, Soulioti E, Kyprianidou M. Mandatory Vaccination against COVID-19: Qualitative Analysis of Responses to Open-Ended Questions. Hygiene. 2023;3: 291–305. doi: 10.3390/hygiene3030021 [DOI] [Google Scholar]
  • 46.Leach M, MacGregor H, Akello G, Babawo L, Baluku M, Desclaux A, et al. Vaccine anxieties, vaccine preparedness: Perspectives from Africa in a Covid-19 era. Soc Sci Med. 2022;298: 114826. doi: 10.1016/j.socscimed.2022.114826 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Poncin M, Marembo J, Chitando P, Sreenivasan N, Makwara I, Machekanyanga Z, et al. Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine–Harare, Zimbabwe, 2019. Vaccine X. 2022;12: 100201. doi: 10.1016/j.jvacx.2022.100201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.LaMontagne DS, Manangazira P, Marembo J, Chigodo C, Zvamashakwe C, Tshuma E, et al. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls. Vaccine. 2022;40: A58–A66. doi: 10.1016/j.vaccine.2021.07.012 [DOI] [PubMed] [Google Scholar]
  • 49.Crawshaw J, Konnyu K, Castillo G, van Allen Z, Grimshaw JM, Presseau J. Behavioural determinants of COVID-19 vaccination acceptance among healthcare workers: a rapid review. Public Health. 2022;210: 123–133. doi: 10.1016/j.puhe.2022.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bauernfeind S, Hitzenbichler F, Huppertz G, Zeman F, Koller M, Schmidt B, et al. Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020. Infection. 2021;49: 1307–1311. doi: 10.1007/s15010-021-01622-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chew NWS, Cheong C, Kong G, Phua K, Ngiam JN, Tan BYQ, et al. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. Int J Infect Dis. 2021;106: 52–60. doi: 10.1016/j.ijid.2021.03.069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Berry SD, Johnson KS, Myles L, Herndon L, Montoya A, Fashaw S, et al. Lessons learned from frontline skilled nursing facility staff regarding COVID-19 vaccine hesitancy. J Am Geriatr Soc. 2021;69: 1140–1146. doi: 10.1111/jgs.17136 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002256.r001

Decision Letter 0

Oghenebrume Wariri

21 Aug 2023

PGPH-D-23-01351

Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe:  A mixed methods study

PLOS Global Public Health

Dear Dr. Taruvinga,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Oghenebrume Wariri, MD

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/globalpublichealth/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

Additional Editor Comments (if provided):

Dear Authors,

Kindly ensure that you address ALL the issues raised by Reviewers 1 and 2 by providing a point-by-point response on how you addressed the issues in the manuscript. Please pay attention to the issues related to enhancing the quantitative component of the manuscript. Ensure you include supplementary statistical tests (e.g., binary associations, logistic regression models, etc.) to elaborate the connections between the independent variables and the dependent variable, specifically categorizing healthcare workers into "early" and "late" vaccine recipients. Strengthening the quantitative analysis will provide a better understanding of the factors influencing vaccine uptake among healthcare workers, thus contributing to the robustness of the study's findings.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: I don't know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I appreciate the opportunity to review your mixed-method study aiming to understand vaccine uptake, perceptions, and attitudes among healthcare workers in Zimbabwe. Below are my comments and suggestions that I believe would enhance the quality and impact of your research.

Major Points

Introduction:

• It is imperative for the authors to cite and discuss prior research studies addressing the same research problem. This context will underscore the novelty of your study and help differentiate it from previous attempts.

• Clearly state the aim and objectives of your study at the conclusion of the introduction section to provide a concise overview of your research goals.

Methods:

• In describing your study design as mixed-method, it is crucial to bolster the quantitative component of your manuscript. Authors should employ additional statistical tests (e.g., binary associations, logistic regression models, etc.) to describe and explain the associations between the independent variables and the dependent variable (healthcare workers categorized as receiving the vaccine “early” and those categorized as “late”).

• Authors should provide more information regarding the study population (e.g., what kind of healthcare professionals, students, adults, working facilities, etc.).

• The sampling strategy should be clearly defined and reported in the methods section.

• Authors should clarify how the sample size was determined.

• The authors fail to provide any information in their manuscript that would allow readers to understand how the sample differs from the target population, particularly in terms of key sociodemographic characteristics such as age, gender, and others. This lack of information raises concerns about the representativeness of the sample.

• No information is given regarding a pilot study for testing the survey tools (e.g., questionnaire, interviews, etc.).

• The authors did not provide any information regarding the methods used to collect the data (e.g., questionnaires). Detailed information (e.g., content, type, and number of questions, etc.) on this is crucial for the study’s validity.

• Authors should clarify how they estimated the reliability or internal consistency of the questionnaire used, using, for example, Cronbach’s alpha to measure whether a score is reliable.

• More information should be provided regarding the considerations concerning the literature review (please add the references) and the authors' previous research experience in developing the questionnaire.

• Lines 147-153: Authors need to provide more information and reasoning on how they selected the healthcare professionals that were included in the qualitative study.

• Detailed information should be added about the methods and procedures of the Qualitative Data Analysis (thematic analysis).

• The study should use additional statistical analysis. Specifically, information on how the authors assessed the normality of numeric variables and any relevant assumptions made for the chosen statistical tests or models should be reported to enhance the transparency and reliability of the statistical analysis. Also, information should be added regarding the logistic regression analysis used (e.g., independent and dependent variables, assumptions, etc.)..

Results:

• Detailed findings from the statistical analyses used such as the logistic regression models should be reported in the text of the Results section. The authors should create new tables reporting the results from these analyses, which should be included among the main tables of the manuscript.

• Themes and categories identified from qualitative data analysis should be reported in a corresponding Table.

Discussion:

• Authors should compare their findings not only with studies conducted in Zimbabwe but also with other studies.

• The discussion section should explore the underlying meaning of the research and its potential implications in other areas of study. It would be beneficial for the authors to discuss how their findings contribute to the existing knowledge and highlight the significance of their research within a broader context. Additionally, they should consider addressing possible improvements or future directions that can further develop the concerns of their research.

• Additional limitations should be added in the limitations section.

• Line 473: It is necessary to include a discussion of the levels of support for a mandatory vaccination policy among HCPs in Zimbabwe and other countries. For example, https://doi.org/10.1016/j.idnow.2021.08.004, https://doi.org/10.3390/ijerph18136688, https://doi.org./10.3389/fpubh.2022.897526 , https://doi.org/10.3390/vaccines9060580 , https://doi.org/10.3390/vaccines9080889 , https://doi.org/10.3390/hygiene3030021 ) and other articles could be added.

General Points:

• Tables should be reviewed for typos.

• The authors could go through the manuscript once more to correct language errors.

Reviewer #2: 

The authors should consider addressing the issues raised below to improve the overall quality of the manuscript

Line 73 Their roll-out has reduced morbidity, severity and deaths [1–3].

Comment: The sentence is a bit short kindly provide more detail.

Line 75 and 77

Comment: What is vaccine nationalism? Define it.

Line 81 For instance Zimbabwe, the focus of our research, did not initially sign up…

Comment: Re-read and edit this sentence slightly

Line 93 …high-income and LMICs suggest…

Comment: Write high-income countries instead

Line 100 …priority group with a target set to reach 100% COVID-19 vaccine coverage among this group [18].

Comment: Reach them by which year?

Line 102 …vaccination strategies were successful…

Comment: Which past vaccination strategies? All of them or COVID-19 related?

Line 110: Data was collected as part of a study providing a comprehensive health check to healthcare workers in…

Comment: Would be clearer to say data was collected as part of another study.

Line 112: …interviews were conducted with selected healthcare workers accessing the service between June 2021…

Comment: Accessing what service?

Line 126: The country approved the use of Sinopharm and Sinovac…

Comment: You mean Sinopharm and Sinovac vaccines.

Line 124 Zimbabwe’s COVID-19 vaccination campaign

Comment: Very nicely written section on the history and flow of events

Line 137 …third wave primarily driven by the delta variant which resulted in the highest number of deaths…

Comment: Be more specific. You mean third wave of the COVID-19 pandemic. What is the delta variant?

Line 143 Procedures

Comment: An overall comment about this section is to sign post where you switch from speaking about a qualitative in-depth interview to a quantitative questionnaire/survey. E.g. on line 151 write “For the qualitative in-depth interviews…” to match with line 159 where you state “…as part of the quantitative questionnaire…”

Line 144 Following verbal informed consent and prior to accessing the health check…

Comment: What is the health check? Good to detail here at first instance as you go on to mention it further down in this section.

Line 146 and 147 Questions about perceived vaccine safety were based on a WHO survey tool [18].

Comment: Where did you get guidance questions about vaccine uptake?

Line 147 and 148 Written informed consent from selected healthcare workers was obtained for in-depth interviews…

Comment: State how you got informed consent for those who took the questionnaire.

Lines 147 to 149 Written informed consent from selected healthcare workers was obtained for in-depth interviews to better understand healthcare workers reasons for taking or not taking up the COVID-19 vaccine and the challenges they may have faced in the process.

Comment: Best to break up this sentence. First, you mean to say that written informed consent was obtained from all selected healthcare workers. Second, you mean to say that in-depth interviews were used to better understand healthcare workers reasons for taking or not taking up the COVID-19 vaccine and the challenges they may have faced in the process. I recommend you give a citation here on the use of in-depth interviews in research.

Line 151 For the in-depth interviews, healthcare workers were purposively selected…

Comment: Briefly define what it means to purposively select participants and provide citation.

Line 153 A total of 17 in-depth interviews were conducted, after reaching a data saturation point [29].

Comment: Expand briefly on the meaning of data saturation.

Line 162 The interviews were conducted in English, Ndebele, or Shona according…

Comment: Do you mean both the interviews and questionnaires?

Line 164 …all possible probing questions.

Comment: Define what probing questions are and why you needed to use them.

Line 173 …of June 2021, while somebody receiving the first vaccine dose after June 2021 was categorised as “late”.

Comment: Instead of “somebody” write “those”

Line 188 In-depth interviews were audio-recorded, transcribed, and translated. During the interview, research…

Comment: Transcribed and translated by who?

Line 191 …software NVivo 12, which was used to perform thematic analysis. Thematic analysis was performed on…

Comment: Describe in more detail what thematic analysis is and how you did it.

Line 195 Quantitative findings were triangulated with the themes emerging from the qualitative data throughout the…

Comment: Good starting explanation of mixed methods data analysis but need to detail more.

Line 203 …waived the necessity for a written informed consent to facilitate access to the service.

Comment: How would written informed consent have been a deterrent to access to the service?

Lines 438-447 Beyond the broader patterns of access, availability, and distribution, we identified several socio behavioural influencers that contributed to a comparatively high vaccine uptake.

Comment: Are these socio behavioural influencers also found in published literature?

Line 498 The strengths of this study lie in the use of a mixed-method approach investigating self-reported vaccine…

Comment: Add one more sentence on why mixed -method approach is a strength.

Line 503 …subject to social desirability and/or recall bias (specifically the date of vaccination). Also, healthcare…

Comment: Define social desirability

Line 505 …may have introduced selection bias as those healthcare workers who took up the health check service…

Comment: Define selection bias

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr. Penda Johm

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: response.pdf

Attachment

Submitted filename: Review Manuscript Number PGPH-D-23-01351.docx

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002256.r003

Decision Letter 1

Oghenebrume Wariri

3 Nov 2023

Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe:  A mixed methods study

PGPH-D-23-01351R1

Dear Mr Taruvinga,

We are pleased to inform you that your manuscript 'Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe:  A mixed methods study' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Oghenebrume Wariri, MD

Academic Editor

PLOS Global Public Health

***********************************************************

We are pleased that you incorporated the feedback provided by the reviewers into your revised manuscript and provided a point-by-point response to their comments. I wish your team well in your future research endeavours.

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I don't know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: You addressed all my comments but please make sure to address those of anonymous reviewer #1, especially taking time to detail your methods and findings from the statistical analyses. I also agree that it would read better if you instead reported the themes and categories identified from qualitative data analysis in a table as the quotes are making the results section longer.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr. Penda Johm

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PGPH-D-23-01351 inclusivity questionnaire.

    The form has been filled in as per the Plos Global Health inclusivity requirements.

    (DOCX)

    S1 Table. Multivariable logistic regression investigating the association between client characteristics and receiving the vaccine late or never receiving the vaccine (n = 1,551).

    The table illustrates the results of a multivariable logistic regression sensitivity analysis. The p-value was derived using a likelihood ratio test and the abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval.

    (DOCX)

    S2 Table. Healthcare workers COVID-19 vaccine uptake emerging themes, codes, and additional quotes.

    The table has three columns showing themes, codes, and relevant supporting quotes that emerged from the qualitative thematic data analysis.

    (DOCX)

    Attachment

    Submitted filename: response.pdf

    Attachment

    Submitted filename: Review Manuscript Number PGPH-D-23-01351.docx

    Attachment

    Submitted filename: Manuscript rebuttal letter.docx

    Data Availability Statement

    Data are available open access via London School of Hygiene and Tropical Medicine (LSHTM) Data Compass https://doi.org/10.17037/DATA.00003679.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES